Areas of Focus
- Tumor Immunology
- Tumor Immunotherapy
- Tumor Metabolism
- Tumor Biomechanics
- Low-dose Cyclophosphamide Treatment
- Tumor Vesicle Therapy
Work Experience
- Current - Beijing Union Medical College - Distinguished Professor
- Current - Chinese Society of Immunology - Vice Chairman and Executive Deputy Secretary-General
- Current - International Union of Immunological Societies (IUIS) - Education Committee Member
- Current - Chinese Society of Immunology Tumor Immunology and Tumor Biotherapy Committee - Chairman
- Current - Chinese Anti-Cancer Association Tumor Biotherapy Committee - Secretary-General
Publications
- Soft fibrin gels promote selection and growth of tumorigenic cells., Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, Poh YC, Tang K, Wang N, Huang B*, 2012
- Tumor-repopulating cells transfer kynurenine to upregulate PD-1 expression in tumor-specific CD8+ T cells through AhR activation., Liu Y, Liang X, Dong W, Lv J, Fiskesund R, Xie J, Jin X, Degao Chen, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Wang J, Hu Z, Cao X, Qin F, Huang B*, 2018
- Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T cell memory development., Zhang H, Tang K, Ma J, Zhou L, Liu J, Zeng L, Zhu L, Xu P, Chen J, Wei K, Liang X, Lv J, Xie J, Liu Y, Wan Y, Huang B*, 2020
- A Pck1-directed glycogen 1 metabolic program regulates formation and maintenance of memory CD8+ T cells., Ma R, Ji T, Zhang H, Dong W, Chen X, Xu P, Chen D, Ma J, Tang K, Zhang Y, Peng Y, Lu J, Zhang Y, Qin X, Cao X, Wan Y, Huang B*, 2018
- Mobilization of neutrophils by MTX-packaging tumor microparticles confers treatment efficacy for obstructive cholangiocarcinoma., Gao Y, Zhang H, Zhou N, Xu P, Wang J, Gao Y, Jin X, Liang X, Lv J, Zhang Y, Tang K, Ma J, Zhang H, Xie J, Yao F, Tong W, Liu Y*, Wang X *, Huang B*, 2020
- Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome., Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, Xie J, Gao Y, Cheng F, Zhou Y, Zhang Z, Hu Y, Zhang X, Gao Q, Zhang Y, Huang B*, 2020
- J Clin Invest., Liu Y, Lv J, Liu J, Liang X, Jin X, Xie J, Chen D, Fiskesund R, Dong W, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Hu Z, Cao X, Qin F, Huang B*, 2018
- Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles., Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, Xu P, Sun Y, Ma R, Ji T, Chen J, Zhang S, Zhang T, Luo S, Hu Z, Cao X, Wang N, Yang X, Huang B*, 2016